Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 233Lung Neoplasms 96Adenocarcinoma of Lung 39Colorectal Neoplasms 21Adenocarcinoma, Bronchiolo-Alveolar 19Neoplasms 18Small Cell Lung Carcinoma 13Non-Squamous Non-Small Cell Lung Cancer 13Brain Neoplasms 13Neoplasm Metastasis 10Ovarian Neoplasms 9Pleural Effusion, Malignant 8Breast Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Meningeal Carcinomatosis 7Mesothelioma 6Melanoma 6Endometrial Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Rectal Neoplasms 4Non-squamous Non-small Cell Lung Cancer 4Carcinoma, Renal Cell 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Non-small Cell Lung Cancer Metastatic 3Mesothelioma, Malignant 3Esophageal Neoplasms 3Colonic Neoplasms 3

Interventions

irinotecan sucrosofate 1atezolizumab 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Mucinous × Bevacizumab × Thoracic × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡